Summary Sandoz Inc (Sandoz), a division of Novartis AG, is a generic pharmaceutical company that develops, manufactures and distributes and sells a range of prescription medicines and protein and biotechnology-based products known as biosimilars. The company also provides intermediary products including active pharmaceutical ingredients (APIs), as well as biotechnology manufacturing services to other companies. It provides active ingredients and finished dosage forms of pharmaceuticals in the areas of dermatology, cancer, cardiovascular, respiratory, metabolism, central nervous system (CNS), pain, ophthalmic, gastrointestinal and hormonal therapies. Sandoz distributes its products to wholesalers, pharmacies, hospitals and other healthcare outlets. Sandoz is headquartered in Princeton, New Jersey, the US. Sandoz Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their... Research Beam Model: Research Beam Product ID: 1996475 250 USD New
Sandoz Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Sandoz Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : August   2017
  • Pages : 26
  • Publisher : GlobalData
 
 
 
Summary

Sandoz Inc (Sandoz), a division of Novartis AG, is a generic pharmaceutical company that develops, manufactures and distributes and sells a range of prescription medicines and protein and biotechnology-based products known as biosimilars. The company also provides intermediary products including active pharmaceutical ingredients (APIs), as well as biotechnology manufacturing services to other companies. It provides active ingredients and finished dosage forms of pharmaceuticals in the areas of dermatology, cancer, cardiovascular, respiratory, metabolism, central nervous system (CNS), pain, ophthalmic, gastrointestinal and hormonal therapies. Sandoz distributes its products to wholesalers, pharmacies, hospitals and other healthcare outlets. Sandoz is headquartered in Princeton, New Jersey, the US.

Sandoz Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sandoz Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sandoz Inc, Medical Devices Deals, 2011 to YTD 2017 9
Sandoz Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sandoz Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Accelis Pharma Enters into Distribution Agreement with Fougera Pharma 11
Medicines Company Enters into Distribution Agreement with Sandoz for Angiomax 12
Fougera Pharma Enters into Co-Promotion Agreement with Women’s Choice Pharma for Veregen 13
Anacor Pharma Amends Co-Marketing Agreement with Sandoz for Kerydin 14
Licensing Agreements 16
Sandoz and Beximco Pharma Enter into Licensing Agreement with Medicines Patent Pool 16
Vectura Group Enters Into Licensing Agreement With Sandoz For VR315 17
BioQuiddity Expands Licensing Agreement with Sandoz 18
Asset Transactions 19
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 19
Acquisition 20
Novartis Completes Acquisition Of Fougera Pharma, Dermatology Company, For US$1.5 Billion 20
Sandoz Inc - Key Competitors 22
Sandoz Inc - Key Employees 23
Sandoz Inc - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Jun 20, 2016: Sandoz Announced Plans for Five Major Global Biosimilar Launches by 2020 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Sandoz Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sandoz Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sandoz Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Sandoz Inc, Medical Devices Deals, 2011 to YTD 2017 9
Sandoz Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Accelis Pharma Enters into Distribution Agreement with Fougera Pharma 11
Medicines Company Enters into Distribution Agreement with Sandoz for Angiomax 12
Fougera Pharma Enters into Co-Promotion Agreement with Women’s Choice Pharma for Veregen 13
Anacor Pharma Amends Co-Marketing Agreement with Sandoz for Kerydin 14
Sandoz and Beximco Pharma Enter into Licensing Agreement with Medicines Patent Pool 16
Vectura Group Enters Into Licensing Agreement With Sandoz For VR315 17
BioQuiddity Expands Licensing Agreement with Sandoz 18
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 19
Novartis Completes Acquisition Of Fougera Pharma, Dermatology Company, For US$1.5 Billion 20
Sandoz Inc, Key Competitors 22
Sandoz Inc, Key Employees 23
Sandoz Inc, Other Locations 24
Sandoz Inc, Subsidiaries 24
List of Figures
Sandoz Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sandoz Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sandoz Inc, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter